<DOC>
	<DOCNO>NCT00617201</DOCNO>
	<brief_summary>This placebo-controlled , double-blind , randomized pilot clinical trial evaluate atomoxetine ( StratteraÂ® ) treatment cocaine dependence . Cocaine-dependent individual , healthy seek treatment substance abuse , randomize receive either atomoxetine ( n=25 ) matched-placebo ( n=25 ) trial last 12 week ; double-blind , ascend dose lead-in order achieve maintenance assign active dose safely . Contingency management procedure use reinforce attendance compliance study procedure . Primary outcome measure include urinalysis data assess cocaine use .</brief_summary>
	<brief_title>Evaluation Atomoxetine Cocaine Dependence : A Pilot Trial</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Seeking treatment cocaine dependence Must use cocaine past 30 day Physical dependence drug require medical management Any major medical psychiatric disorder would contraindicate participation Cardiovascular disease Seizures significant head injury Currently take atomoxetine Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>cocaine</keyword>
	<keyword>dependence</keyword>
	<keyword>stimulant</keyword>
</DOC>